focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSF.L Regulatory News (NSF)

  • There is currently no data for NSF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Recapitalisation & Directorate Change 

18 May 2023 07:00

RNS Number : 7975Z
Non-Standard Finance PLC
18 May 2023
 

Non-Standard Finance plc

('Non-Standard Finance', 'NSF' or the 'Company')

Update on proposed recapitalisation ('Proposed Recapitalisation') and Directorate Change

(18 May 2023): Further to its announcement dated 17 March 2023 regarding the launch of the Scheme and Proposed Recapitalisation or Alternative Transaction (the "17 March RNS") and its announcement dated 14 April 2023 providing an update on the Proposed Recapitalisation, the Board of Non-Standard Finance announces that Alchemy, the Group's largest shareholder, has informed the Company that it is no longer willing, in the current environment, to participate in the equity raise under the Proposed Recapitalisation on the previously notified proposed terms. The Group continues to press ahead with the Scheme and both the Proposed Recapitalisation and the Alternative Transaction, but if the Scheme is successful, the Board now feels that the Alternative Transaction is a more likely outcome than the Proposed Recapitalisation.

The Alternative Transaction will involve the transfer of the Group's business to the secured lenders in exchange for the release of a portion of their secured debt and the provision of a new lending facility. Part of the proceeds from this new lending facility would be used to fund the Scheme Fund and cover the costs of the Scheme.

Both the Alternative Transaction and the Proposed Recapitalisation will secure the future of the Everyday Loans business and allow it to pursue its growth plans providing an invaluable service for its customers. However, the Proposed Recapitalisation will materially dilute the interests of NSF's existing shareholders, most likely to negligible value, unless they choose to participate in the equity raise, and the Alternative Transaction will unfortunately result in no recovery for NSF's shareholders. The Board is continuing to consider a range of options for the NSF plc ultimate parent company in the event the Alternative Transaction is implemented, but the most likely outcome is an orderly winddown following implementation of the Alternative Transaction. In the event that the Scheme is not sanctioned by the Court, or the Scheme is sanctioned but the Proposed Recapitalisation and the Alternative Transaction both fail, then the Group would remain insolvent and the most likely outcome would be a Group-wide insolvency (most likely administration), also resulting in no return for current shareholders.

Following the communication from Alchemy regarding its position, Toby Westcott, the Alchemy nominee non-executive director of the Company, has stepped down as a director of the Company with immediate effect.

Unless otherwise defined, capitalised terms within this announcement shall have the same meaning as those contained within the 17 March RNS.

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. The person responsible for arranging the release of this announcement on behalf of Non-Standard Finance plc is Sarah Day, Chief ESG Officer and Group Company Secretary.

For more information:

Non-Standard Finance plc

+44 203 869 9020

Jono Gillespie, Group Chief Executive Officer

Sarah Day, Chief ESG Officer and Company Secretary

Cenkos Securities plc 

+44 207 397 8900

Nicholas Wells

Ben Jeynes

Callum Davidson

H/Advisors Maitland

+44 207 379 5151

Neil Bennett

+44 7900 000777

Finlay Donaldson

+44 7341 788066

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFIFAWEDSEEI
Date   Source Headline
11th Mar 20222:00 pmRNSShareholder Update
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Dec 20213:56 pmRNSDirector/PDMR Shareholding
17th Dec 20213:52 pmRNSResults of General Meeting
2nd Dec 20217:00 amRNSAppointment of financial adviser and broker
1st Dec 20214:41 pmRNSSecond Price Monitoring Extn
1st Dec 20214:36 pmRNSPrice Monitoring Extension
27th Oct 20214:40 pmRNSSecond Price Monitoring Extn
27th Oct 20214:35 pmRNSPrice Monitoring Extension
14th Oct 20214:36 pmRNSPrice Monitoring Extension
1st Oct 20214:06 pmRNSDirector/PDMR Shareholding
28th Sep 20214:37 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSUnaudited Half Year Results to 30 June 2021
24th Sep 20212:48 pmRNSPublication of 2021 half year results
10th Sep 20214:35 pmRNSPrice Monitoring Extension
31st Aug 20217:00 amRNSDirectorate Change
27th Aug 20214:35 pmRNSPrice Monitoring Extension
26th Aug 20214:36 pmRNSPrice Monitoring Extension
24th Aug 20217:00 amRNSHolding(s) in Company - Correction
23rd Aug 20211:31 pmRNSHolding(s) in Company
23rd Aug 20211:30 pmRNSHolding(s) in Company
18th Aug 20214:35 pmRNSPrice Monitoring Extension
16th Aug 20214:54 pmRNSResults of General Meeting
6th Aug 20214:41 pmRNSSecond Price Monitoring Extn
6th Aug 20214:35 pmRNSPrice Monitoring Extension
1st Jul 20212:47 pmRNSDirector/PDMR Shareholding
30th Jun 20212:09 pmRNSResult of AGM
30th Jun 20218:54 amRNSAudited full year results to 31 December 2020
30th Jun 20217:02 amRNSAudited full year results to 31 December 2020
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:36 pmRNSPrice Monitoring Extension
15th Jun 20217:00 amRNSNotification of results and trading update
17th May 20214:41 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
16th Apr 20214:40 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
14th Apr 20214:41 pmRNSSecond Price Monitoring Extn
14th Apr 20214:35 pmRNSPrice Monitoring Extension
26th Mar 20213:37 pmRNSPurchase of shares - Non-Executive Director fees
23rd Feb 20217:00 amRNSTrading Update
8th Jan 20214:41 pmRNSSecond Price Monitoring Extn
8th Jan 20214:36 pmRNSPrice Monitoring Extension
17th Dec 20207:00 amRNSDirector/PDMR Shareholding
5th Nov 202012:05 pmEQSHardman & Co Research: Non-Standard Finance Plc (NSF): 1H'20 results:
2nd Nov 20203:56 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSUnaudited Half Year Results to 30 June 2020
23rd Oct 20204:40 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
30th Sep 202010:06 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.